
### [MONDO:0017719](http://purl.obolibrary.org/obo/MONDO_0017719)
**Label:** gangliosidosis

**Subclasses:** [MONDO:0009260](http://purl.obolibrary.org/obo/MONDO_0009260) (GM1 gangliosidosis type 1), [MONDO:0017721](http://purl.obolibrary.org/obo/MONDO_0017721) (Sandhoff disease, infantile form), [MONDO:0009261](http://purl.obolibrary.org/obo/MONDO_0009261) (GM1 gangliosidosis type 2), [MONDO:0017720](http://purl.obolibrary.org/obo/MONDO_0017720) (GM2 gangliosidosis), [MONDO:0009262](http://purl.obolibrary.org/obo/MONDO_0009262) (GM1 gangliosidosis type 3), [MONDO:0018149](http://purl.obolibrary.org/obo/MONDO_0018149) (GM1 gangliosidosis), [MONDO:0017723](http://purl.obolibrary.org/obo/MONDO_0017723) (Sandhoff disease, adult form), [MONDO:0017722](http://purl.obolibrary.org/obo/MONDO_0017722) (Sandhoff disease, juvenile form), [MONDO:0010099](http://purl.obolibrary.org/obo/MONDO_0010099) (Tay-Sachs disease AB variant), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0017728](http://purl.obolibrary.org/obo/MONDO_0017728) (Tay-Sachs disease, B1 variant), [MONDO:0017725](http://purl.obolibrary.org/obo/MONDO_0017725) (Tay-Sachs disease, b variant, juvenile form), [MONDO:0017724](http://purl.obolibrary.org/obo/MONDO_0017724) (Tay-Sachs disease, b variant, infantile form), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), [MONDO:0017726](http://purl.obolibrary.org/obo/MONDO_0017726) (Tay-Sachs disease, b variant, adult form), 

**Corr. equiv. classes:** [OMIM:272800](http://purl.obolibrary.org/obo/OMIM_272800), [Orphanet:354](http://www.orpha.net/ORDO/Orphanet_354), [Orphanet:309192](http://www.orpha.net/ORDO/Orphanet_309192), [Orphanet:309162](http://www.orpha.net/ORDO/Orphanet_309162), [Orphanet:309152](http://www.orpha.net/ORDO/Orphanet_309152), [Orphanet:309185](http://www.orpha.net/ORDO/Orphanet_309185), [Orphanet:309155](http://www.orpha.net/ORDO/Orphanet_309155), [OMIM:268800](http://purl.obolibrary.org/obo/OMIM_268800), [Orphanet:309178](http://www.orpha.net/ORDO/Orphanet_309178), [Orphanet:309246](http://www.orpha.net/ORDO/Orphanet_309246), [Orphanet:309169](http://www.orpha.net/ORDO/Orphanet_309169), [Orphanet:309239](http://www.orpha.net/ORDO/Orphanet_309239), [OMIM:230650](http://purl.obolibrary.org/obo/OMIM_230650), [OMIM:230600](http://purl.obolibrary.org/obo/OMIM_230600), [OMIM:230500](http://purl.obolibrary.org/obo/OMIM_230500), [Orphanet:845](http://www.orpha.net/ORDO/Orphanet_845), [Orphanet:79255](http://www.orpha.net/ORDO/Orphanet_79255), [Orphanet:79256](http://www.orpha.net/ORDO/Orphanet_79256), [Orphanet:796](http://www.orpha.net/ORDO/Orphanet_796), [Orphanet:79257](http://www.orpha.net/ORDO/Orphanet_79257), [OMIM:272750](http://purl.obolibrary.org/obo/OMIM_272750), 

**Class expressions from DL-Learner:**

- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 57.59%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation))) 56.55%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0005561](http://purl.obolibrary.org/obo/HP_0005561) (Abnormality of bone marrow cell morphology))) 56.55%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema))) 56.55%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 55.11%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 55.11%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 55.11%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 55.11%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 55.11%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 55.11%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0012144](http://purl.obolibrary.org/obo/HP_0012144) (Abnormality of cells of the monocyte/macrophage lineage))) 54.85%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion))) 54.85%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0010974](http://purl.obolibrary.org/obo/HP_0010974) (Abnormality of myeloid leukocytes))) 54.85%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0004311](http://purl.obolibrary.org/obo/HP_0004311) (Abnormality of macrophages))) 54.85%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and (not ([HP:0000943](http://purl.obolibrary.org/obo/HP_0000943) (Dysostosis multiplex))) 54.85%


